Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors

Discovery of Novel 1,2,3-triazole Derivatives as IDO1 Inhibitors

Indoleamine 2,3-dioxygenase 1 (IDO1) has received much attention as an immunomodulatory enzyme in the field of cancer immunotherapy. While several IDO1 inhibitors have entered clinical trials, there are currently no IDO1 inhibitor drugs on the market. To explore potential IDO1 inhibitors, we designe...

Full description

Bibliographic Details
Main Authors:	Xixi Hou, Xiaoqing Gong, Longfei Mao, Jie Zhao, Jianxue Yang
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	Pharmaceuticals
Subjects:	indoleamine 2,3-dioxygenase 1 1,2,3-triazole molecular docking quantum mechanical studies
Online Access:	https://www.mdpi.com/1424-8247/15/11/1316

Similar Items

Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors
by: Long-fei Mao, et al.
Published: (2020-09-01)

Synthesis and activity study of novel N,N-diphenylurea derivatives as IDO1 inhibitors
by: Xi-Xi Hou, et al.
Published: (2023-06-01)

Synthesis, Docking and Biological Evaluation of a Novel Class of Imidazothiazoles as IDO1 Inhibitors
by: Marta Serafini, et al.
Published: (2019-05-01)

Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on Ortho-Naphthaquinone-Containing Natural Product
by: Hongchuan Zhao, et al.
Published: (2019-03-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
by: Thiara Manuele Alves de Souza, et al.
Published: (2022-04-01)

Discovery of a Series of Theophylline Derivatives Containing 1,2,3-Triazole for Treatment of Non-Small Cell Lung Cancer
by: Jiahui Ye, et al.
Published: (2021-10-01)

On the nonredundant roles of TDO2 and IDO1
by: Paolo ePuccetti
Published: (2014-10-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
by: Yu Yao, et al.
Published: (2021-02-01)

Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer
by: Ge Sun, et al.
Published: (2022-01-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
by: Cemil Bilir, M.D., et al.
Published: (2017-07-01)

Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies
by: Gui-Qing Xu, et al.
Published: (2022-05-01)

IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients
by: Marie Beck Hairing Enemark, et al.
Published: (2023-04-01)

Single-nucleotide polymorphisms and activities of indoleamine 2,3-dioxygenase isoforms, IDO1 and IDO2, in tuberculosis patients
by: Tingming Cao, et al.
Published: (2022-01-01)

5-Formyltriazoles as Valuable Starting Materials for Unsymmetrically Substituted Bi-1,2,3-Triazoles
by: Robby Vroemans, et al.
Published: (2020-04-01)

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity
by: Huaxia Xie, et al.
Published: (2023-10-01)

5-Methyl-N′-(5-methyl-1-phenyl-1H-1,2,3-triazole-4-carbonyl)-1-phenyl-1H-1,2,3-triazole-4-carbohydrazide
by: Gamal A. El-Hiti, et al.
Published: (2018-03-01)

Discovery of cyanopyridine scaffold as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors through virtual screening and preliminary hit optimisation
by: Xi Xu, et al.
Published: (2019-01-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Spiro-Oxindole Skeleton Compounds Are Efficient Inhibitors for Indoleamine 2,3-Dioxygenase 1: An Attractive Target for Tumor Immunotherapy
by: Daojing Yan, et al.
Published: (2022-04-01)

Progesterone decreased indoleamine 2,3-dioxygenase 1(IDO1) expression in early pregnancy chorionic villi and decidua
by: Minyan Yang, et al.
Published: (2021-04-01)

Synthesis of new 1H-1,2,3-triazole-1,4-naphthoquinones
by: Wagner O. Valença, et al.
Published: (2012-06-01)

New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity
by: Mohamed T-E Maghraby, et al.
Published: (2023-10-01)

1-(4-Fluorophenyl)-5-methyl-N′-{1-[5-methyl-1-(4-methylphenyl)-1H-1,2,3-triazol-4-yl]ethylidene}-1H-1,2,3-triazole-4-carbohydrazide
by: Gamal A. El-Hiti, et al.
Published: (2019-02-01)

Heterociclos 1,2,3-triazólicos: histórico, métodos de preparação, aplicações e atividades farmacológicas 1,2,3-triazolic heterocycles: history, preparations, applications and pharmacological activities
by: Júlio O. F. Melo, et al.
Published: (2006-06-01)

4-(4-(((1<i>H</i>-Benzo[d][1,2,3]triazol-1-yl)oxy)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)-7-chloroquinoline
by: Leong Ka Fai, et al.
Published: (2022-07-01)

Synthesis methods of 1,2,3-/1,2,4-triazoles: A review
by: Jinlian Dai, et al.
Published: (2022-09-01)

Immunomodulatory Factors in Primary Endometrial Cell Cultures Isolated from Cancer and Noncancerous Human Tissue–Focus on RAGE and IDO1
by: Joanna Tkaczuk-Włach, et al.
Published: (2021-04-01)

New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation
by: Wael A. El-Sayed, et al.
Published: (2022-09-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
by: Eleonora Panfili, et al.
Published: (2023-04-01)

Synthesis, in silico ADME, molecular docking and in vitro cytotoxicity evaluation of stilbene linked 1,2,3-triazoles
by: Arnika Das, et al.
Published: (2021-01-01)

Differentiation between Isomeric 4,5-Functionalized 1,2,3-Thiadiazoles and 1,2,3-Triazoles by ESI-HRMS and IR Ion Spectroscopy
by: Dmitrii M. Mazur, et al.
Published: (2023-01-01)

Synthesis and Antitumor Activity of Erlotinib Derivatives Linked With 1,2,3-Triazole
by: Peng Deng, et al.
Published: (2022-01-01)

Syntheses and Applications of 1,2,3-Triazole-Fused Pyrazines and Pyridazines
by: Gavin R. Hoffman, et al.
Published: (2022-07-01)

Recent Progress in Catalytic Synthesis of 1,2,3-Triazoles
by: Antonio De Nino, et al.
Published: (2021-09-01)

Synthesis of newer substituted chalcone linked 1,2,3-triazole analogs and evaluation of their cytotoxic activities
by: Raghavender Matta, et al.
Published: (2022-10-01)

Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
by: Trevor W. Stone, et al.
Published: (2023-05-01)

1-(2′-Ethoxy-4′-fluoro-[1,1′-biphenyl]-4-yl)-4-phenyl-1H-1,2,3-triazole
by: Maryam Gilandoust, et al.
Published: (2016-10-01)

Combination of 1,2,3-triazole and 1,2,4-triazole frameworks for new high-energy and low-sensitivity compounds
by: Wenjing Yao, et al.
Published: (2021-06-01)

Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors
by: Chuan Zhou, et al.
Published: (2020-03-01)